UBS Group AG - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 113 filers reported holding GW PHARMACEUTICALS PLC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$7,711,000
+45.2%
35,553
-22.7%
0.00%
+50.0%
Q4 2020$5,312,000
-11.4%
46,021
-25.3%
0.00%
-33.3%
Q3 2020$5,995,000
-44.7%
61,586
-30.3%
0.00%
-40.0%
Q2 2020$10,850,000
-28.7%
88,413
-49.1%
0.01%
-28.6%
Q1 2020$15,221,000
-59.2%
173,809
-51.3%
0.01%
-46.2%
Q4 2019$37,282,000
+135.1%
356,560
+158.6%
0.01%
+116.7%
Q3 2019$15,860,000
-16.2%
137,877
+25.5%
0.01%
-14.3%
Q2 2019$18,935,000
+20.7%
109,838
+18.0%
0.01%
+16.7%
Q1 2019$15,687,000
+86.6%
93,059
+7.8%
0.01%
+50.0%
Q4 2018$8,406,000
-53.1%
86,316
-16.8%
0.00%
-42.9%
Q3 2018$17,925,000
+55.9%
103,768
+25.9%
0.01%
+40.0%
Q2 2018$11,498,000
+23.1%
82,396
-0.6%
0.01%
+25.0%
Q1 2018$9,341,000
+48.7%
82,911
+74.2%
0.00%
+33.3%
Q4 2017$6,283,000
+27.8%
47,593
-1.7%
0.00%
+50.0%
Q3 2017$4,916,000
+54.2%
48,436
+52.3%
0.00%0.0%
Q2 2017$3,188,000
-87.6%
31,799
-85.0%
0.00%
-86.7%
Q1 2017$25,720,000
-8.8%
212,669
-15.7%
0.02%
-6.2%
Q4 2016$28,206,000
+597.1%
252,395
+727.9%
0.02%
+700.0%
Q3 2016$4,046,000
-38.2%
30,485
-57.3%
0.00%
-60.0%
Q2 2016$6,544,000
+855.3%
71,461
+652.9%
0.01%
Q1 2016$685,000
+2.9%
9,492
-1.1%
0.00%
Q4 2015$666,000
+1.7%
9,599
+33.9%
0.00%
Q3 2015$655,000
-11.1%
7,168
+19.4%
0.00%
Q2 2015$737,000
+22.8%
6,001
-8.9%
0.00%
Q1 2015$600,000
-10.6%
6,586
-33.7%
0.00%
Q4 2014$671,0009,9270.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders